"Tastemakers" Launches as a First-of-Its-Kind Collaboration Between Dolphin Subsidiaries The Door and The Digital Dept., Pioneering New Model of Talent Management and Earned Media

LOS ANGELES, CA / ACCESS Newswire / August 13, 2025 / Dolphin (NASDAQ:DLPN), the award-winning entertainment, marketing and media company, today announced the launch of Dolphin Tastemakers, a new division formed through a strategic collaboration between subsidiaries The Digital Dept. and The Door. Tastemakers delivers a unique, full-service model for culinary and lifestyle creators – pairing talent management and brand strategy with premier PR and amplification services.

The Dolphin Tastemakers roster includes influential chefs, media personalities, and cultural trendsetters across food, beverage, and lifestyle who have active social followings. These creators gain access to a full menu of services within the Dolphin ecosystem. Talent management is provided by the culinary and lifestyle specialists at The Digital Dept., who secure brand partnerships, product collaborations, and IP development opportunities to help monetize and grow influence. In addition, creators have the opportunity for premier earned media representation from The Door’s award-winning PR team, renowned for their expertise in representing culinary and lifestyle talent.

The roster includes culinary and lifestyle talent such as New York Times #1 Best-selling cookbook author and host of Mythical Kitchen’s viral show Last Meals Josh Scherer (@mythicalchefjosh), New York Times best-selling cookbook author and recipe developer Jeanine Donofrio (@loveandlemons), lifestyle homemaking and hosting creator Jessica Bui (@the.orange.home) and Mexican-American chef and cookbook author Alfredo Garcia (@freddsters).

"Creators and lifestyle icons typically engage separate firms for management representation and publicity, often leading to disconnected strategies and missed opportunities. We’ve eliminated that friction," said Bill O’Dowd, CEO of Dolphin. "Our teams now work as one unit from the outset, crafting cohesive strategies that maximize both commercial opportunities and cultural relevance. The Door’s PR campaigns keep these talent top of mind for both brand managers and the public at large while The Digital Dept. monetizes that cultural cache for the talent through brand partnerships and endorsements. This creates a virtuous flywheel for the talent. More visibility through PR and earned media leads to the ability to capitalize on greater endorsement potential."

The division reflects Dolphin’s broader vision of offering a 360-degree approach to its clients and partners across its collective of agencies. Tastemakers clients can gain direct access to the expansive Dolphin ecosystem, including production, events, product development, affiliate services, and more.

"What’s special here is that our PR and influencer management teams don’t just work in parallel – they feed each other in real time. The right media coverage builds credibility and demand, which opens the door to bigger deals. Those deals, in turn, create more stories to tell and more moments to amplify. It’s a growth loop that keeps building on itself, and only Dolphin has the structure and expertise to make it happen seamlessly, said Lois Najarian O’Neill, Co-Founder and Co-CEO of The Door.

"With Tastemakers, we’re tapping into a real passion for food and lifestyle creators who shape culture every day," said Sarah Boyd, co-CEO of The Digital Dept. "This division isn’t just about business – it’s about celebrating the stories behind great food and lifestyle brands, and giving creators the management muscle and access to best in class PR that they need to turn their passion into lasting success, both online and beyond."

ABOUT DOLPHIN

Named the #1 Agency of the Year by the Observer in 2025, Dolphin (NASDAQ:DLPN) is a strategic marketing consultancy comprised of top executives from the leading firms across every marketing practice- public relations, influencer and social media marketing, talent management, branding, talent booking, events, and social impact – including 42West, The Door, Shore Fire Media, Elle Communications, Special Projects, The Digital Dept., and Always Alpha. Its long-standing Entertainment division produces acclaimed film, television, and digital content with high-profile partners, while at the nucleus is a venture incubator that develops and accelerates breakthrough ideas, products, and experiences, powered by Dolphin’s unmatched cross-marketing expertise and relationships across every vertical of pop culture from entertainment, music, sports, hospitality and fashion to consumer brands, and purpose-driven initiatives.

###

CONTACT:

James Carbonara
Hayden IR
james@haydenir.com
646-755-7412

SOURCE: Dolphin Entertainment

View the original press release on ACCESS Newswire

"Tastemakers" Launches as a First-of-Its-Kind Collaboration Between Dolphin Subsidiaries The Door and The Digital Dept., Pioneering New Model of Talent Management and Earned Media

LOS ANGELES, CA / ACCESS Newswire / August 13, 2025 / Dolphin (NASDAQ:DLPN), the award-winning entertainment, marketing and media company, today announced the launch of Dolphin Tastemakers, a new division formed through a strategic collaboration between subsidiaries The Digital Dept. and The Door. Tastemakers delivers a unique, full-service model for culinary and lifestyle creators – pairing talent management and brand strategy with premier PR and amplification services.

The Dolphin Tastemakers roster includes influential chefs, media personalities, and cultural trendsetters across food, beverage, and lifestyle who have active social followings. These creators gain access to a full menu of services within the Dolphin ecosystem. Talent management is provided by the culinary and lifestyle specialists at The Digital Dept., who secure brand partnerships, product collaborations, and IP development opportunities to help monetize and grow influence. In addition, creators have the opportunity for premier earned media representation from The Door’s award-winning PR team, renowned for their expertise in representing culinary and lifestyle talent.

The roster includes culinary and lifestyle talent such as New York Times #1 Best-selling cookbook author and host of Mythical Kitchen’s viral show Last Meals Josh Scherer (@mythicalchefjosh), New York Times best-selling cookbook author and recipe developer Jeanine Donofrio (@loveandlemons), lifestyle homemaking and hosting creator Jessica Bui (@the.orange.home) and Mexican-American chef and cookbook author Alfredo Garcia (@freddsters).

"Creators and lifestyle icons typically engage separate firms for management representation and publicity, often leading to disconnected strategies and missed opportunities. We’ve eliminated that friction," said Bill O’Dowd, CEO of Dolphin. "Our teams now work as one unit from the outset, crafting cohesive strategies that maximize both commercial opportunities and cultural relevance. The Door’s PR campaigns keep these talent top of mind for both brand managers and the public at large while The Digital Dept. monetizes that cultural cache for the talent through brand partnerships and endorsements. This creates a virtuous flywheel for the talent. More visibility through PR and earned media leads to the ability to capitalize on greater endorsement potential."

The division reflects Dolphin’s broader vision of offering a 360-degree approach to its clients and partners across its collective of agencies. Tastemakers clients can gain direct access to the expansive Dolphin ecosystem, including production, events, product development, affiliate services, and more.

"What’s special here is that our PR and influencer management teams don’t just work in parallel – they feed each other in real time. The right media coverage builds credibility and demand, which opens the door to bigger deals. Those deals, in turn, create more stories to tell and more moments to amplify. It’s a growth loop that keeps building on itself, and only Dolphin has the structure and expertise to make it happen seamlessly, said Lois Najarian O’Neill, Co-Founder and Co-CEO of The Door.

"With Tastemakers, we’re tapping into a real passion for food and lifestyle creators who shape culture every day," said Sarah Boyd, co-CEO of The Digital Dept. "This division isn’t just about business – it’s about celebrating the stories behind great food and lifestyle brands, and giving creators the management muscle and access to best in class PR that they need to turn their passion into lasting success, both online and beyond."

ABOUT DOLPHIN

Named the #1 Agency of the Year by the Observer in 2025, Dolphin (NASDAQ:DLPN) is a strategic marketing consultancy comprised of top executives from the leading firms across every marketing practice- public relations, influencer and social media marketing, talent management, branding, talent booking, events, and social impact – including 42West, The Door, Shore Fire Media, Elle Communications, Special Projects, The Digital Dept., and Always Alpha. Its long-standing Entertainment division produces acclaimed film, television, and digital content with high-profile partners, while at the nucleus is a venture incubator that develops and accelerates breakthrough ideas, products, and experiences, powered by Dolphin’s unmatched cross-marketing expertise and relationships across every vertical of pop culture from entertainment, music, sports, hospitality and fashion to consumer brands, and purpose-driven initiatives.

###

CONTACT:

James Carbonara
Hayden IR
james@haydenir.com
646-755-7412

SOURCE: Dolphin Entertainment

View the original press release on ACCESS Newswire

TAMPA, FL / ACCESS Newswire / August 13, 2025 / Specificity, Inc. (OTCID:SPTY), a leading digital marketing agency blending proprietary ad tech with cutting-edge strategy, is finalizing development of its fully in-house, company-owned AI technology stack – a powerful asset set to redefine how the company scales, drives efficiency, and maintains its edge in the marketplace.

Over the past year, while much of the industry grappled with unprecedented disruption following the BF Borgers auditing firm scandal, Specificity turned a challenge into a growth catalyst. Of the 109 micro-cap companies affected, Specificity was one of, if not the only to regain its fully reporting status – an achievement its advisors call significant in an environment where many peers were forced to delist or dissolve.

With stability secured, CEO Jason Wood led a decisive pivot toward innovation:

• Built its own data asset of exclusively organic MAIDs for adtech targeting

• Began designing, training, and refining a proprietary AI-powered marketing technology stack entirely in-house – now nearing launch. This stack delivers mass automation and powers faster tactical campaign changes leading to better results.

• Began training AI to focus ad spend on organic traffic and parse out bot and mechanical traffic PRE ad spend.

Once live, the platform will allow Specificity to operate leaner, scale faster, and position itself within a technology asset class that commands significantly higher market multiples than traditional digital marketing agencies.

"Our AI stack is more than an upgrade – it’s the future of how we’ll dominate this space," said Jason Wood, CEO of Specificity. "By owning every aspect of development, we’re building a competitive advantage that can’t be replicated by plug-and-play solutions. We’re not just ready for the next phase of growth – we’re building it."

As the company prepares for the formal launch of its proprietary AI platform, Specificity stands ready to lead an evolving digital marketing landscape where precision, performance, and proprietary technology define success.

About Specificity
Specificity is a performance-driven digital marketing agency built on proprietary technology that guarantees campaigns reach human audiences and delivers highly qualified, in-market leads at a fraction of the cost of traditional pay-per-click. Combining advanced data targeting, AI-powered creative optimization, and a no-BS approach, Specificity helps businesses dominate their markets. To learn more visit www.specificityinc.com.

Media Contact:
Chris Gruening
Vice President, Client Services
chris@specificityinc.com

SOURCE: Specificity Inc.

View the original press release on ACCESS Newswire

PHOENIX, AZ / ACCESS Newswire / August 12, 2025 / New Generation Consumer Group Inc. (OTC PINK:NGCG), a Delaware corporation, announced today that its wholly owned subsidiary, Signature Apps, Inc., has filed a trademark application for QuickLend™, a proprietary metasearch application and web development solution tailored for the Merchant Cash Advance (MCA) marketplace. This marks a significant step in the company’s ongoing expansion within the rapidly growing fintech sector.

QuickLend™ is a cutting-edge platform designed to enhance connectivity and streamline the transaction process between MCA lenders and merchants. As demand for alternative lending solutions continues to surge, QuickLend™ aims to become a central tool for improving market efficiency, reducing friction, and increasing transparency across the MCA ecosystem.

The MCA industry, valued at approximately $50 billion, is experiencing accelerated growth as small businesses increasingly turn to alternative financing options. QuickLend™ is positioned to capitalize on this trend by offering a metasearch solution that simplifies the process for both merchants seeking funding and lenders looking for quality deals. By integrating sophisticated search capabilities and robust web development tools, QuickLend™ enables stakeholders to engage in faster, more informed decision-making.

Key Features of QuickLend™ Include:

• Metasearch Capabilities: Streamlines comparison of funding options for merchants and lenders.

• Improved User Experience: Provides an intuitive, transparent interface designed for ease of use.

• End-to-End Solution: Combines search functionality with backend automation to enhance operational efficiency for both parties.

"We believe QuickLend™ will drive substantial value for both MCA lenders and small business owners, filling a critical gap in the marketplace," said Jacob DiMartino, CEO for New Generation Consumer Group. "By developing this platform, Signature Apps is positioning itself as a leader in a fast-growing sector, and we are excited about the long-term revenue potential this product holds."

The filing of the QuickLend™ trademark is part of New Generation Consumer Group’s broader strategy to expand its presence in high-growth fintech verticals, specifically those related to alternative financing. The company believes that QuickLend™ will provide substantial monetization opportunities through both licensing and transactional revenues, contributing to shareholder value in the near and long term.

In addition to its progress with QuickLend™, the company emphasizes that its widely recognized RDAR app is not on the back burner. Significant updates are currently in development, with major enhancements expected to roll out soon. Artificial intelligence will play a central role in these upgrades, leveraging advanced technology to help the app protect children more effectively than ever before. By integrating AI-driven monitoring and alert systems, RDAR will strengthen its mission to keep children safe in an increasingly digital and connected world.

As development of QuickLend™ progresses, Signature Apps, Inc. will continue to refine the platform’s features, positioning it to attract significant interest from industry stakeholders.

About New Generation Consumer Group, Inc. (OTC:NGCG)
New Generation Consumer Group Inc. is a Delaware-based publicly traded holding company focused on identifying, acquiring, and scaling innovative businesses in the fintech and digital solutions industries. Through its wholly owned subsidiary, Signature Apps, Inc., the company develops proprietary technologies designed to address inefficiencies in fast-growing sectors, such as alternative finance and merchant services.

Forward-Looking Statements
This release contains forward-looking statements within the meaning of federal securities laws. These statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially.

For more information, please contact:
Investor Relations
New Generation Consumer Group, Inc.
jacob@sigappco.com
855-SIG-APPS
www.sigappco.com

SOURCE: Signature Apps

View the original press release on ACCESS Newswire

TOKYO, JAPAN / ACCESS Newswire / August 12, 2025 / Harrison Global Holdings Inc. (NASDAQ:BLMZ) ("Harrison Global" or the "Company"), a Japanese audio production, V-Tuber, entertainment, and voice actor management company, announced today that it has signed a strategic international business partnership agreement with Biotree Co., Ltd. ("Biotree"), a Korean firm developing the world’s first natural product-based treatment for metabolic syndrome – including diabetes, obesity, hyperlipidemia, and hypertension.

Biotree has successfully completed Phase 1 clinical trials in the United States for PH-100, its natural product-based treatment targeting metabolic syndrome and diabetic complications. Additionally, Biotree has concluded Phase 2A clinical trials across 12 university hospitals in Korea. The Phase 2A clinical trial results confirmed a significant reduction in inflammatory markers (HS-CRP) and showed positive effects on cardiovascular disease without adverse side effects. Pending the successful completion of the ongoing Phase 2B clinical trials, the drug is expected to be conditionally approved and launch as a prescription-only treatment in the first half of 2026.

Among seaweeds, Gamtae stands out for its notable health benefits, including dementia prevention, vascular health support, and anticancer effects – often called the ocean’s natural nutrient. Biotree is the first Korean company to extract "Seapolynol," a marine polyphenol, from Gamtae, and has since developed and sold a diverse range of products spanning health functional foods, pharmaceuticals, daily necessities, and cosmetics. Biotree has quietly expanded its presence in both domestic and international markets.

Since 2008, Biotree has led the industry in Korea by being the first to obtain certifications such as U.S. FDA’s NDI (New Dietary Ingredient) and IND (Investigational New Drug), and the European EFSA NFI (Novel Food Ingredient) certification. It has also registered and issued over 50 patents and published over 130 SCI (Science Citation Index)-level papers.

Dr. Eui-Shin Kim, a world-renowned oncologist and a leader in nuclear medicine, serves as a senior advisor to Biotree. He served as a tenured professor at the University of Texas MD Anderson Cancer Center for 32 years and has gained recognition for his research on cancer diagnostic techniques utilizing genetic analysis and MRI. His exceptional achievements have earned him eleven honors as one of America’s Best Doctors.

Harrison Global Holdings plans to actively pursue the global expansion of Biotree’s new drug technology and raw materials for metabolic syndrome treatments, including exports to markets such as the US, Japan, China, and Asia. Under the partnership, the scope of operations includes, but is not limited to:

• Establishing a joint venture or licensing agreement for operations in local countries

• Joint development of new natural product drugs and their localization in each country

• Sharing of branding, distribution channels, and technological infrastructure

• Cooperation in introducing and developing local partners

• Regulatory compliance, media strategy, and local PR support

Ryoshin Nakade, Co-CEO of Harrison Global Holdings, stated, "Through this partnership, we are delighted to contribute to human health by working with Biotree to complete the development of a natural metabolic syndrome treatment that has taken considerable time and investment to develop and enter the global market. We look forward to working closely with the Biotree team to support the joint development and distribution of its products."

About Harrison Global Holdings Inc.
Harrison Global Holdings Inc. (formerly BloomZ Inc.) is a holding company headquartered in the Cayman Islands, operating BloomZ Japan in Japan. BloomZ Japan is engaged in sound production for anime and games, as well as the management, training, and promotion of voice actors and VTubers. In recent years, it has also focused on developing and promoting next-generation entertainment businesses.

Cautionary Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as "will," "expects," "anticipates," "aims," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.

Harrison Global Holdings Inc. Investor Contact
John Yi and Steven Shinmachi
Gateway Group, Inc.
949-574-3860
Email: bloomz@gateway-grp.com

SOURCE: Harrison Global Holdings Inc.

View the original press release on ACCESS Newswire

TOKYO, JAPAN / ACCESS Newswire / August 12, 2025 / Harrison Global Holdings Inc. (NASDAQ:BLMZ) ("Harrison Global" or the "Company"), a Japanese audio production, V-Tuber, entertainment, and voice actor management company, announced today that it has signed a strategic international business partnership agreement with Biotree Co., Ltd. ("Biotree"), a Korean firm developing the world’s first natural product-based treatment for metabolic syndrome – including diabetes, obesity, hyperlipidemia, and hypertension.

Biotree has successfully completed Phase 1 clinical trials in the United States for PH-100, its natural product-based treatment targeting metabolic syndrome and diabetic complications. Additionally, Biotree has concluded Phase 2A clinical trials across 12 university hospitals in Korea. The Phase 2A clinical trial results confirmed a significant reduction in inflammatory markers (HS-CRP) and showed positive effects on cardiovascular disease without adverse side effects. Pending the successful completion of the ongoing Phase 2B clinical trials, the drug is expected to be conditionally approved and launch as a prescription-only treatment in the first half of 2026.

Among seaweeds, Gamtae stands out for its notable health benefits, including dementia prevention, vascular health support, and anticancer effects – often called the ocean’s natural nutrient. Biotree is the first Korean company to extract "Seapolynol," a marine polyphenol, from Gamtae, and has since developed and sold a diverse range of products spanning health functional foods, pharmaceuticals, daily necessities, and cosmetics. Biotree has quietly expanded its presence in both domestic and international markets.

Since 2008, Biotree has led the industry in Korea by being the first to obtain certifications such as U.S. FDA’s NDI (New Dietary Ingredient) and IND (Investigational New Drug), and the European EFSA NFI (Novel Food Ingredient) certification. It has also registered and issued over 50 patents and published over 130 SCI (Science Citation Index)-level papers.

Dr. Eui-Shin Kim, a world-renowned oncologist and a leader in nuclear medicine, serves as a senior advisor to Biotree. He served as a tenured professor at the University of Texas MD Anderson Cancer Center for 32 years and has gained recognition for his research on cancer diagnostic techniques utilizing genetic analysis and MRI. His exceptional achievements have earned him eleven honors as one of America’s Best Doctors.

Harrison Global Holdings plans to actively pursue the global expansion of Biotree’s new drug technology and raw materials for metabolic syndrome treatments, including exports to markets such as the US, Japan, China, and Asia. Under the partnership, the scope of operations includes, but is not limited to:

• Establishing a joint venture or licensing agreement for operations in local countries

• Joint development of new natural product drugs and their localization in each country

• Sharing of branding, distribution channels, and technological infrastructure

• Cooperation in introducing and developing local partners

• Regulatory compliance, media strategy, and local PR support

Ryoshin Nakade, Co-CEO of Harrison Global Holdings, stated, "Through this partnership, we are delighted to contribute to human health by working with Biotree to complete the development of a natural metabolic syndrome treatment that has taken considerable time and investment to develop and enter the global market. We look forward to working closely with the Biotree team to support the joint development and distribution of its products."

About Harrison Global Holdings Inc.
Harrison Global Holdings Inc. (formerly BloomZ Inc.) is a holding company headquartered in the Cayman Islands, operating BloomZ Japan in Japan. BloomZ Japan is engaged in sound production for anime and games, as well as the management, training, and promotion of voice actors and VTubers. In recent years, it has also focused on developing and promoting next-generation entertainment businesses.

Cautionary Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as "will," "expects," "anticipates," "aims," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.

Harrison Global Holdings Inc. Investor Contact
John Yi and Steven Shinmachi
Gateway Group, Inc.
949-574-3860
Email: bloomz@gateway-grp.com

SOURCE: Harrison Global Holdings Inc.

View the original press release on ACCESS Newswire

CALABASAS, CA AND ABU DHABI, UAE / ACCESS Newswire / August 11, 2025 / NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), a multi-Phase 2 clinical-stage biotechnology company pioneering therapies for central nervous system (CNS) cancers, today announced the official incorporation of NuroMENA Holdings Ltd. by the Abu Dhabi Global Market (ADGM). This milestone marks the fulfillment of all contingencies required to finalize the previously announced $50 million cornerstone investment from Quazar Investment into NuroMENA Holdings Ltd.

This strategic alliance will accelerate the launch of NeOnc’s innovative CNS platform across the MENA region and fast-track development of its clinical programs, including NEO212 and NEO100, two advanced therapies with the potential to transform outcomes for brain cancer and other CNS conditions.

"We view this as a defining moment for NeOnc and a major validation of our global vision," said Amir Heshmatpour, Executive Chairman and President of NeOnc Technologies. "With the finalization of NuroMENA’s incorporation and the support of Quazar Investment, we are now fully equipped to advance our mission of delivering life-saving therapies to a region in urgent need of innovation. This partnership not only brings capital-it brings conviction, commitment, and alignment of purpose."

Waleed K. Al Ali, Chairman and CEO of Quazar Investment, commented: "We are proud to partner with NeOnc to bring cutting-edge biotechnology to the UAE and beyond. With NuroMENA now officially formed under ADGM, we are positioned to help NeOnc transform the landscape of brain cancer and CNS treatment across the region. This is just the beginning."

Vince Caruso, CEO and Creator of New to The Street, added:

"This is precisely the kind of groundbreaking international deal that showcases the strength of our clients on a global stage. NeOnc’s ability to secure a $50 million strategic investment from a powerhouse like Quazar Investment reflects both the company’s scientific leadership and its vision for transforming healthcare in the MENA region. At New to The Street, we’re proud to amplify this story to millions through our nationwide Bloomberg and FOX Business broadcasts, our business YouTube channel with over 3.2 million subscribers, and our 711,000+ followers, friends, and connections across X, Facebook, LinkedIn, and Instagram. With over 16 years in business and more than 2,000 interviews broadcast, our platform ensures that strategic business developments like this receive the maximum visibility and credibility they deserve."

About NuroMENA Holdings Ltd.

NuroMENA is a UAE-based subsidiary of NeOnc Technologies Holdings, Inc., created to oversee regional clinical operations, partnerships, and innovation in the Middle East and North Africa. Upon closing of the $50 million investment and execution of the change of control, NuroMENA will be majority-controlled by Quazar Investment, with joint governance oversight and strategic alignment between NeOnc and Quazar to accelerate breakthrough CNS therapies across the region. NuroMENA was officially incorporated under ADGM on August 6, 2025.

About NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI)

NeOnc Technologies is a multi-Phase 2 clinical-stage biotechnology company focused on novel therapies for brain cancer and other CNS disorders. With a robust intellectual property portfolio and strong academic collaborations, NeOnc is committed to transforming outcomes in one of the hardest-to-treat areas of oncology.

About Quazar Investment

Quazar Investment is a leading strategic investment firm headquartered in Abu Dhabi, managing over $3.3 billion in assets under management (AUM). Backed by key partnerships with the UAE Government, Quazar focuses on transformative investments in biotechnology, healthcare, and next-generation infrastructure across the MENA region and globally.

About New to The Street (NTTS)

New to The Street is one of the longest-running U.S. and international television brands, broadcasting sponsored programming weekly on Bloomberg and FOX Business networks, while leveraging one of the largest business YouTube channels with over 3.2 million subscribers. NTTS maintains an expansive social footprint with 711,000+ followers, friends, and connections across X, Facebook, LinkedIn, and Instagram. With over 16 years in business and more than 2,000 interviews broadcast, NTTS specializes in elevating corporate visibility through long-form interviews, targeted social media, and high-impact outdoor campaigns in Times Square and other iconic locations.

Media Contact:
info@neonc.com

Investor Contact:
James Carbonara – Hayden IR
(646) 755-7412
James@haydenir.com

Grace@NewtoTheStreet.com

SOURCE: New To The Street

View the original press release on ACCESS Newswire

by Ashlan and Philippe Cousteau

NORTHAMPTON, MA / ACCESS Newswire / August 11, 2025 / To the far south, in the icy ancient waters around Antarctica, the largest climate catastrophe in the history of our planet is unfolding, potentially devastating our planet for generations to come, but you’ve probably never heard about it. Krill, the small but mighty lynchpin for the entire Antarctic marine ecosystem and the food that feeds the entire global marine food web, are being taken from their natural habitat at enormous rates primarily for one really stupid reason: the mass production of Omega-3 supplements. Ripped out of the water and away from the diets from keystone species like whales, dolphins, and penguins, these krill are mashed up in massive industrial processors, compressed down into tiny gel capsules destined for the health section of your local pharmacy.

The demand makes total sense: as our planet teeters on the brink of climate catastrophe, human health trends increasingly turn to nature in search of resilience. Omega-3 fatty acids, long hailed for their cardiovascular and cognitive benefits, have sparked massive global demand. Yet the irony could not be starker: in seeking to heal ourselves, we are wreaking havoc on the health of one of Earth’s most critical ecosystems.

But there is another way – an answer that does not come at the cost of abusing the Southern Ocean to trigger ecological collapse. SeaVoir, a pioneering venture in the rising tide of the blue economy co-founded by my husband, Philippe Cousteau, and I, offers a bold, necessary alternative: an algae-based Omega-3 supplement that honors both human wellness and oceanic integrity. In doing so, SeaVoir’s goal is not only to change the supplement industry – we hope to chart a course toward a future where the health of people and the ocean move forward together.

Read their full article here – https://greenmoney.com/saving-our-southern-ocean-one-algae-based-omega-3-supplement-at-a-time

====

View additional multimedia and more ESG storytelling from GreenMoney Journal on 3blmedia.com.

Contact Info:
Spokesperson: GreenMoney Journal
Website: https://www.3blmedia.com/profiles/greenmoney-journal
Email: info@3blmedia.com

SOURCE: GreenMoney Journal

View the original press release on ACCESS Newswire

NEW YORK, NY / ACCESS Newswire / August 11, 2025 / New to The Street proudly spotlights its esteemed client, NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), which today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for NRX-100 in the treatment of suicidal ideation in patients with depression, including bipolar depression.

This designation represents a 10-fold expansion in the potential patient population compared to the FDA’s 2017 Fast Track designation for bipolar depression alone – now encompassing the 13 million U.S. adults who consider suicide each year. The FDA’s decision also recognizes NRX-100’s potential to address an unmet medical need, qualifying it for eligibility under the Commissioner’s National Priority Voucher Program (CNPV) and accelerated approval pathways.

Supported by multiple large-scale, well-controlled trials – including pivotal studies from Columbia University and the Government of France – NRX-100 (preservative-free IV ketamine) demonstrated rapid and statistically significant reductions in suicidal ideation, in some cases doubling remission rates compared to placebo.

"We thank the FDA for its thoughtful review of our Fast Track designation request," said Dr. Jonathan Javitt, Chairman & CEO of NRx Pharmaceuticals. "This recognition is a major step toward addressing the national crisis of suicide affecting civilians, soldiers, veterans, and first responders. We are committed to working closely with the FDA to bring this life-saving therapy to those who need it most."

"At New to The Street, we are honored to help share NRx Pharmaceuticals’ groundbreaking achievements with millions of viewers across our national television platforms," said Vince Caruso, Co-Founder & CEO of New to The Street. "FDA Fast Track designation is not just a regulatory milestone – it’s a pivotal moment in the fight against one of our nation’s most urgent public health crises, and we’re proud to help amplify this story."

A First-in-Class Formulation

NRX-100’s preservative-free formulation offers a key safety advantage by eliminating benzethonium chloride – a toxic preservative found in some ketamine products – and is manufactured in the U.S. with a three-year room-temperature shelf life. The Company has initiated U.S. high-volume manufacturing and filed a Citizen Petition to remove benzethonium chloride from all IV ketamine products.

Next Steps Under Fast Track

Under the program, NRx will seek Accelerated Approval and Priority Review, post an expanded access policy within two weeks, and engage FDA leadership to finalize its data package for review. The Company’s goal is to expand access to this potentially life-saving treatment to all Americans, beyond those currently able to pay out-of-pocket.

With the U.S. suicidal depression market estimated at over $3 billion annually, this milestone has both profound societal impact and significant commercial potential.

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) is a clinical-stage biopharmaceutical company developing breakthrough therapeutics based on its NMDA platform to address serious central nervous system disorders, including suicidal depression, chronic pain, and PTSD. The Company’s lead candidates include NRX-100, a preservative-free intravenous ketamine formulation awarded Fast Track Designation by the U.S. Food and Drug Administration (FDA) for the treatment of suicidal ideation in depression, including bipolar depression, and NRX-101, an oral fixed-dose combination of D-cycloserine and lurasidone, awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression.

NRx has recently filed both an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application (NDA) for NRX-100, alongside an application for the Commissioner’s National Priority Voucher Program. These filings are supported by data from well-controlled clinical trials conducted under the auspices of the U.S. National Institutes of Health and the Government of France, licensed to NRx under a formal data-sharing agreement.

For more information, please visit www.nrxpharma.com.

About New to The Street

New to The Street is a leading, nationally broadcast television and multi-platform media brand delivering in-depth profiles of public and private companies, innovative entrepreneurs, and industry leaders. Since 2009, New to The Street has aired weekly on Fox Business and Bloomberg as sponsored programming, reaching over 224 million homes weekly across the U.S. and internationally. Its New to The Street TV YouTube channel boasts 3.17 million subscribers, making it one of the largest financial media channels on the platform. Company-wide, New to The Street commands an audience of over 711,000 followers across X, Facebook, LinkedIn, and Instagram, delivering unmatched social media amplification.

Beyond TV and digital, New to The Street generates over 20 million monthly outdoor billboard impressions through its network of iconic billboards in Times Square and the NYC Financial District, further enhancing visibility for its featured companies. Integrating long-form TV interviews, earned media placements, outdoor campaigns, and proprietary Opportunities To Consider™ segments, New to The Street delivers unparalleled exposure, credibility, and investor reach. Learn more at www.newtothestreet.com.

Media contact

Grace@NewtoTheStreet.com

SOURCE: New To The Street

View the original press release on ACCESS Newswire

Series debuts with celebrations for Apple TV+’s "Chief of War" and Prime Video’s "Butterfly" featuring cast and creators

LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 11, 2025 / Gold House, the home of collective power where leaders unite to forge culture, and OpenTable are joining forces to launch the Family Dinner Series. This series sheds light on the profound connection between food and cultural storytelling through exclusive family dinners, beginning with two celebrations in honor of Apple TV+’s "Chief of War" and Prime Video’s "Butterfly."

The Family Dinner Series will feature two gatherings that position food as the ultimate cultural bridge. The first honors the August 1st premiere of Apple TV+’s "Chief of War," Jason Momoa’s epic nine-episode historical drama following the unification of Hawaii from an indigenous perspective. The second celebrates the August 13th premiere of Prime Video’s "Butterfly," Daniel Dae Kim’s character-driven spy thriller that bridges American and Korean storytelling, marking Kim’s first solo lead television role.

These two dinners will be hosted at prestigious restaurants on OpenTable’s vast restaurant network and will showcase the finest in Asian Pacific culinary excellence. AB Steak is honoring "Butterfly" with a menu featuring Korean cuisine by Michelin-Starred chef Akira Back. Camelia is honoring "Chief of War" with a Hawaiian-inspired menu by Chef Charles Namba, created in collaboration with Chef Robynne Maii from Hawaii’s Fête. Camelia is also making these Hawaiian-inspired dishes available to diners for a limited time in August. Cast and creators from both productions will join these intimate celebrations, enabling direct cultural exchange between creatives across industries.

The Family Dinner Series represents the continuation of Gold House and OpenTable’s long-standing partnership to champion Asian Pacific restaurants, chefs, and culture. This collaboration has previously included the Gold Chef Prize, which gave a platform to exceptional Asian Pacific chefs, and collaboration on the prestigious dinners at the Gold Gala (the most-viewed gathering of the Asian Pacific diaspora in North America), which have featured MICHELIN-starred restaurants and James Beard Award winners.

About Gold House

Gold House is the home of collective power where leaders unite to forge culture.

We foster spaces where established and emerging makers gather to amplify their impact. We shape public perceptions by consulting on, investing in, and marketing society-defining media properties. We create new economies by backing the boldest entrepreneurs and scaling them internationally.

By fueling unity, visibility, and economic mobility, success becomes our shared world. With roots in Los Angeles, New York City, San Francisco, and Singapore, Gold House operates with the heart of a nonprofit and the scale of a world-class enterprise.

About OpenTable

OpenTable, a global leader in restaurant tech and part of Booking Holdings, Inc., helps more than 60,000 restaurants worldwide fill 1.8 billion seats a year. OpenTable’s world-class technology empowers restaurants to focus on what matters most – their team, their guests, and their bottom line – while enabling diners to discover and book the perfect restaurant for every occasion.

Media Contactpress@goldhouse.org

View the original press release on ACCESS Newswire